E-MTAB-1457 - Transcription profiling by array of human hepatitis B inactive carrier male blood to investigate response to Telbivudine treatment
Released on 1 January 2014, last updated on 13 March 2014
Comparing 4 groups of human subjects: hepatitis B inactive carriers (n = 3), baseline (n = 2), patients receiving telbivudine treatment for 6 months (n = 2), and patients receiving treatment for one year (n = 3).
transcription profiling by array, array platform variation, co-expression, compound treatment
Decrease of serum Angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glumerular filtration rates. Liang KH, Chen YC, Hsu CW, Chang ML, Yeh CT. Hepat Mon 14(1):e15074 (2014), Europe PMC 24596580